Novo Nordisk teams up with Microsoft for faster and scaled use of AI in drug discovery 14-Sep-2022 By Jane Byrne Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud, and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development, and data science capabilities.